Q3 2024 |
25 |
$1.08B |
+$293M |
-$142M |
+$151M |
SOLV, GHC, LBRDK, WLY, GMED
|
13F-HR |
11/14/2024, 06:23 AM |
Q2 2024 |
20 |
$792M |
+$320M |
-$156M |
+$165M |
GHC, SOLV, GMED, TBPH, WLY
|
13F-HR |
8/14/2024, 06:52 AM |
Q1 2024 |
18 |
$620M |
+$141M |
-$266M |
-$124M |
GHC, SN, TBPH, WLY, HES
|
13F-HR |
5/15/2024, 06:07 AM |
Q4 2023 |
19 |
$708M |
+$99.6M |
-$217M |
-$118M |
SN, GHC, TBPH, STGW, IART
|
13F-HR |
2/16/2024, 11:27 AM |
Q3 2023 |
20 |
$705M |
+$312M |
-$60.2M |
+$252M |
SN, GHC, GIII, TBPH, IART
|
13F-HR |
11/14/2023, 06:06 AM |
Q2 2023 |
19 |
$458M |
+$65.5M |
-$89.3M |
-$23.8M |
GHC, GIII, TBPH, STGW, IART
|
13F-HR |
8/14/2023, 06:16 AM |
Q1 2023 |
18 |
$465M |
+$49.9M |
-$159M |
-$109M |
GHC, TBPH, GIII, STGW, MBC
|
13F-HR |
5/15/2023, 06:17 AM |
Q4 2022 |
22 |
$565M |
+$167M |
-$110M |
+$57.1M |
GHC, TBPH, SMCI, ONL, STGW
|
13F-HR |
2/14/2023, 06:18 AM |
Q3 2022 |
18 |
$466M |
+$59M |
-$98.5M |
-$39.5M |
GHC, TBPH, SLVM, SMCI, STGW
|
13F-HR |
11/14/2022, 04:14 PM |
Q2 2022 |
16 |
$489M |
+$102M |
-$117M |
-$15.1M |
GHC, TBPH, SLVM, WTM, SMCI
|
13F-HR |
8/15/2022, 12:00 PM |
Q1 2022 |
18 |
$536M |
+$149M |
-$51.2M |
+$97.6M |
GHC, TBPH, SMCI, SLVM, STGW
|
13F-HR |
5/16/2022, 12:05 PM |
Q4 2021 |
16 |
$462M |
+$113M |
-$111M |
+$2.22M |
GHC, TBPH, SMCI, SLVM, STGW
|
13F-HR |
2/14/2022, 02:11 PM |
Q3 2021 |
17 |
$451M |
+$179M |
-$62.7M |
+$116M |
GHC, ATGE, SMCI, JRVR, NABL
|
13F-HR |
11/15/2021, 03:07 PM |
Q2 2021 |
14 |
$335M |
+$84.5M |
-$90.7M |
-$6.25M |
GHC, SMCI, JRVR, ATGE, MDCA
|
13F-HR |
8/16/2021, 02:44 PM |
Q1 2021 |
14 |
$326M |
+$68.5M |
-$44.6M |
+$24M |
SMCI, GHC, ATGE, WTM, CARR
|
13F-HR |
5/17/2021, 02:23 PM |
Q4 2020 |
12 |
$275M |
+$75.7M |
-$129M |
-$53.1M |
SMCI, GHC, ATGE, FE, CARR
|
13F-HR |
2/12/2021, 04:57 PM |
Q3 2020 |
16 |
$279M |
+$50.9M |
-$45.6M |
+$5.3M |
SMCI, CARR, DD, GHC, ATGE
|
13F-HR |
11/13/2020, 05:54 PM |
Q2 2020 |
18 |
$254M |
+$68.6M |
-$57.8M |
+$10.8M |
SMCI, DD, CARR, ATGE, GHC
|
13F-HR |
8/14/2020, 10:19 AM |
Q1 2020 |
18 |
$202M |
+$174M |
-$71.4M |
+$103M |
SMCI, UTX, DD, PCG, ATGE
|
Restatement |
5/22/2020, 09:37 AM |
Q4 2019 |
15 |
$116M |
$0 |
$0 |
|
TRN, GTS, CRCM, NIHD, MDCA
|
13F-HR |
2/14/2020, 10:11 AM |